SCHEMBL10185544

SCHEMBL10185544

O=C1C(N(C(=O)Cc2cccs2)c2cccc(F)c2)c2ccccc2N1C1CCC1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.40
▸ OPRD1 P41143 3/20 0.40
▸ OPRK1 P41145 3/20 0.40
▸ POLB P06746 2/20 0.38
▸ SIGMAR1 Q99720 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ ATM Q13315 1/20 0.34
▸ TAAR1 Q96RJ0 1/20 0.34
▸ CHRM2 P08172 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ AGTR2 P50052 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183666 0.97 OPRM1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10185926 0.97 OPRM1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10183767 0.93 OPRM1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10184153 0.87 OPRM1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10185945 0.87 OPRM1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10184154 0.86 POLB (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10183314 0.85 CCKBR (0.37) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL18074198 0.85 SIGMAR1 (0.39) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10183904 0.84 OPRM1 (0.38) OPRM1OPRD1OPRK1POLBSIGMAR1
SCHEMBL10184095 0.84 TP53 (0.41) OPRM1OPRD1OPRK1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback